Semler Scientific, Inc. (NASDAQ:SMLR) Shares Purchased by Truvestments Capital LLC

Truvestments Capital LLC raised its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 30.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,082 shares of the company’s stock after buying an additional 4,421 shares during the period. Truvestments Capital LLC’s holdings in Semler Scientific were worth $1,030,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of SMLR. US Bancorp DE lifted its position in Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after buying an additional 1,158 shares in the last quarter. Principal Financial Group Inc. acquired a new position in Semler Scientific during the third quarter valued at approximately $361,000. GSA Capital Partners LLP lifted its position in Semler Scientific by 73.9% during the third quarter. GSA Capital Partners LLP now owns 10,336 shares of the company’s stock valued at $243,000 after buying an additional 4,393 shares in the last quarter. Victory Capital Management Inc. lifted its position in Semler Scientific by 202.2% during the third quarter. Victory Capital Management Inc. now owns 19,298 shares of the company’s stock valued at $454,000 after buying an additional 12,912 shares in the last quarter. Finally, Quest Partners LLC lifted its position in Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after buying an additional 817 shares in the last quarter. 49.37% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital lifted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Stock Up 0.2 %

SMLR opened at $32.80 on Wednesday. The firm has a market capitalization of $314.78 million, a P/E ratio of 6.68 and a beta of 1.33. The firm’s 50 day moving average is $50.52 and its 200-day moving average is $43.80. Semler Scientific, Inc. has a 52-week low of $20.88 and a 52-week high of $81.56.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.